Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

FORT LAUDERDALE, FL / ACCESSWIRE / November 6, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals …
Jetzt den vollständigen Artikel lesen